Company News, Financial News

J&J Reports Q1 Results

Consumer health unit reports 11% rise in operational sales.

Johnson & Johnson, which makes Aveeno and Neutrogena and is also working on COVID-10 vaccine candidates, has announced results for first-quarter 2020.  Worldwide sales were $20.6 billion in the quarter, up 3.3%, according to J&J.   J&J’s Consumer Health worldwide operational sales, excluding the net impact of acquisitions and divestitures, grew 11.0% to $3.6 billion, driven primarily by over-the-counter products including its Tylenol and Motrin analgesics, upper respiratory p...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters